Portuguese 
English 
Spanish 
2 min of reading 
0 comments 
Chamber Approves Warning on Medications That May Impair Driving Ability
The Health Commission of the Chamber of Deputies took an important step for traffic safety by approving a project that requires warnings on the labels, package inserts, and advertising materials of medications capable of affecting the ability to drive.
The measure, which aims to raise consumer awareness about the risks of combining driving and certain medications, was included as a substitute by the rapporteur, Deputy Rogéria Santos (Republicanos-BA), to Bill 877/24, authored by Deputy Juninho do Pneu (União-RJ).
“The use of medications associated with driving can significantly increase the risk of traffic accidents,” stated the rapporteur. She emphasized that the initiative will allow consumers to make safer decisions, reducing the likelihood of accidents.
-
For R$ 32,000, a brand new Hyundai car is a rival to the Kwid with a 1.2 engine producing 82 hp, 6 airbags as standard, multimedia with wireless Android Auto, up to 391 liters in the trunk, and a refreshed look for 2026 in India.
-
He bought a new car in 1983, locked it in the barn in 1988, and no one opened the door for 38 years until the family discovered what was stored inside and realized it looked like something out of a movie.
-
A 250cc motorcycle that can reach 560 km with a 14-liter tank, features disc brakes on both wheels and is among the most well-known in Brazil.
-
Man finds over 200 rare cars abandoned on a lot and tries to do the impossible in 8 hours with a surprise at the end.
The proposal amends Law 6.360/76, which regulates health surveillance of medications, expanding the requirements to protect drivers and pedestrians.
The wording of the approved text was carefully adjusted to include the mandatory warnings without excessively burdening the pharmaceutical industry.
The proposal reflects the growing concern for traffic safety, especially in light of frequent reports of accidents associated with the misuse of medications that impair reflexes and attention.
Next Steps in Congress
Now, the project goes for analysis, in a conclusive manner, by the Consumer Defense and Constitution, Justice and Citizenship (CCJ) commissions. If approved in these stages, it will still need to pass a vote in the Chamber and the Senate before being sanctioned and becoming law.
Despite the progress, experts warn that the effectiveness of the measure depends not only on the adoption of the warnings but also on raising public awareness and proper enforcement.
One point that raised questions was the deadline for pharmaceutical companies to adapt to the new requirements, which will still be defined in subsequent regulation. This highlights the importance of open dialogue among government, industry, and society.
With the final approval, it is expected that the initiative will contribute to the reduction of accidents related to the use of medications and driving.
Seja o primeiro a reagir!